pulmonary sarcoidosis

Showing 1 - 25 of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Beryllium Disease to Pulmonary Sarcoidosis

Recruiting
  • Pulmonary Sarcoidosis
  • Chronic Beryllium Disease
    • Bobigny, Avicenne, France
      001 - Service Pneumologie
    Oct 27, 2023

    Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

    Not yet recruiting
    • Pulmonary Sarcoidosis
    • XTMAB-16 or Placebo
    • (no location specified)
    May 25, 2023

    Role of Genetic Factors in the Development of Lung Disease

    Recruiting
    • Cystic Fibrosis
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Pulmonary Sarcoidosis Trial in Cleveland (Efzofitimod 3 mg/kg, Efzofitimod 5 mg/kg, Placebo)

      Recruiting
      • Pulmonary Sarcoidosis
      • Efzofitimod 3 mg/kg
      • +2 more
      • Birmingham, Alabama
      • +22 more
      Dec 1, 2022

      Pulmonary Sarcoidosis Trial in Worldwide (CMK389, Placebo)

      Recruiting
      • Pulmonary Sarcoidosis
      • Birmingham, Alabama
      • +27 more
      Nov 2, 2022

      Pulmonary Sarcoidosis Trial in Istanbul (Exercise- One-Legged, Exercise-Two-Legged)

      Enrolling by invitation
      • Pulmonary Sarcoidosis
      • Exercise- One-Legged
      • Exercise-Two-Legged
      • Istanbul, Turkey
        Istanbul University Cerrahpasa
      Jun 8, 2022

      Pulmonary Sarcoidosis Trial (Hydroxychloroquine + low-dose prednisone, Prednisone)

      Not yet recruiting
      • Pulmonary Sarcoidosis
      • (no location specified)
      Feb 9, 2022

      Pulmonary Sarcoidosis Trial in Columbus (nicotine patch)

      Completed
      • Pulmonary Sarcoidosis
      • nicotine patch
      • Columbus, Ohio
        The Ohio State University
      Nov 1, 2021

      Patients With Suspected Sarcoidosis: The VOCs-IS Study

      Completed
      • Pulmonary Sarcoidosis
      • Breath Analysis
      • +6 more
      • Norwich, Norfolk, United Kingdom
      • +1 more
      Nov 1, 2021

      Pulmonary Sarcoidosis Trial in Germany, Netherlands, United States (ACZ885, Placebo)

      Completed
      • Pulmonary Sarcoidosis
      • Birmingham, Alabama
      • +7 more
      Sep 30, 2021

      Pulmonary Sarcoidosis Trial in United States (ATYR1923 1.0 mg/kg or , ATYR1923 3.0 mg/kg or , ATYR1923 5.0 mg/kg or )

      Completed
      • Pulmonary Sarcoidosis
      • ATYR1923 1.0 mg/kg or placebo
      • +2 more
      • Birmingham, Alabama
      • +14 more
      Jul 21, 2021

      Healthy Subjects, Rheumatoid Arthritis, Vasculitis Trial in Turku ([68Ga]Ga-DOTA-Siglec-9)

      Recruiting
      • Healthy Subjects
      • +3 more
      • [68Ga]Ga-DOTA-Siglec-9
      • Turku, Finland
        Turku University Hospital, Turku PET Centre
      Jun 8, 2021

      Rheumatoid Arthritis, Reactive Arthritis, Ankylosing Spondylitis Trial (Faecal microbiota transplantation, Placebo)

      Not yet recruiting
      • Rheumatoid Arthritis
      • +9 more
      • Faecal microbiota transplantation
      • Placebo
      • (no location specified)
      Jun 7, 2021

      CASPA: CArdiac Sarcoidosis in PApworth

      Recruiting
      • Interstitial Lung Disease
      • +2 more
        • Papworth Everard, Cambridgeshire, United Kingdom
          Royal Papworth Hospital
        Mar 9, 2021

        Pulmonary Sarcoidosis Trial in Edirne (Threshold IMT, breathing exercises combined with upper extremity and trunk)

        Recruiting
        • Pulmonary Sarcoidosis
        • Threshold IMT
        • breathing exercises combined with upper extremity and trunk
        • Edirne, Istanbul, Turkey
          Esma Yıldız
        Feb 13, 2021

        Pulmonary Sarcoidosis Trial in Denver (N-acetyl-cysteine, Placebo)

        Completed
        • Pulmonary Sarcoidosis
        • N-acetyl-cysteine
        • Placebo
        • Denver, Colorado
          National Jewish Health
        Oct 14, 2020

        Pulmonary Sarcoidosis Trial in New York, Cincinnati (PD 0360324, Normal Saline for injection)

        Terminated
        • Pulmonary Sarcoidosis
        • PD 0360324
        • Normal Saline for injection
        • New York, New York
        • +4 more
        Dec 16, 2019

        Pulmonary Sarcoidosis Trial in Charleston (Mycophenolate)

        Terminated
        • Pulmonary Sarcoidosis
        • Charleston, South Carolina
          Medical University of South Carolina
        Jun 14, 2018

        Pulmonary Sarcoidosis Trial in Turku (Methionine, DOTANOC)

        Unknown status
        • Pulmonary Sarcoidosis
        • Turku, Varsinais-Suomi, Finland
          Turku University Hospital
        Jul 1, 2016

        Sarcoidosis, Pulmonary Sarcoidosis Trial in Cincinnati (Acthar gel)

        Unknown status
        • Sarcoidosis
        • Pulmonary Sarcoidosis
        • Acthar gel
        • Cincinnati, Ohio
          University of Cincinnati
        Dec 4, 2015

        Rehabilitation in Pulmonary Sarcoidosis: a Prospective Study

        Unknown status
        • Pulmonary Sarcoidosis
          • Kfar saba, Israel
            Meir medical center
          Apr 8, 2015

          Pulmonary Sarcoidosis Trial in Milano (Prednisone, Hydroxychloroquine + Prednisone)

          Completed
          • Pulmonary Sarcoidosis
          • Milano, Italy
            Università degli Studi di Milano - Bicocca
          Jul 24, 2014

          Pulmonary Sarcoidosis, Lung Function Trial in Nashville (levaquin; ethambutol; rifampin and azithromycin.)

          Completed
          • Pulmonary Sarcoidosis
          • Lung Function
          • levaquin; ethambutol; rifampin and azithromycin.
          • Nashville, Tennessee
            Vanderbilt University School of Medicine
          Oct 26, 2012

          Influenza Vaccine in Patients With Sarcoidosis

          Completed
          • Pulmonary Sarcoidosis
          • Influenza Vaccine
          • Tehran, Iran, Islamic Republic of
            Shahid Modarres Hospital
          May 20, 2009

          Pulmonary Sarcoidosis Trial run by the NHLBI (Pentoxifylline)

          Completed
          • Pulmonary Sarcoidosis
          • Bethesda, Maryland
            National Heart, Lung and Blood Institute (NHLBI)
          Mar 3, 2008